Gyre Therapeutics (GYRE) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to $30.0 million.
- Gyre Therapeutics' Other Gross PP&E Adjustments rose 800.91% to $30.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year increase of 800.91%. This contributed to the annual value of $27.0 million for FY2024, which is 292.45% up from last year.
- Per Gyre Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at $30.0 million for Q3 2025, which was up 800.91% from $29.0 million recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Other Gross PP&E Adjustments registered a high of $30.0 million during Q3 2025, and its lowest value of -$3.3 million during Q4 2021.
- In the last 5 years, Gyre Therapeutics' Other Gross PP&E Adjustments had a median value of $9.8 million in 2022 and averaged $12.6 million.
- As far as peak fluctuations go, Gyre Therapeutics' Other Gross PP&E Adjustments tumbled by 8716.87% in 2021, and later surged by 16236470.59% in 2024.
- Quarter analysis of 5 years shows Gyre Therapeutics' Other Gross PP&E Adjustments stood at -$3.3 million in 2021, then soared by 703.26% to $19.6 million in 2022, then skyrocketed by 33.65% to $26.2 million in 2023, then grew by 2.92% to $27.0 million in 2024, then increased by 11.06% to $30.0 million in 2025.
- Its Other Gross PP&E Adjustments stands at $30.0 million for Q3 2025, versus $29.0 million for Q2 2025 and $29.1 million for Q1 2025.